{"text": "Patient 20 was evaluated for Circulating hepatic transaminase concentrations were elevated. The patient also presented with parkinsonism and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 90, "label": "HPO_TERM"}, {"start": 124, "end": 136, "label": "HPO_TERM"}, {"start": 141, "end": 182, "label": "HPO_TERM"}, {"start": 213, "end": 217, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 21 includes abnormal thalamic signal intensity and eyelids were positioned lower than normal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 79, "label": "HPO_TERM"}, {"start": 84, "end": 125, "label": "HPO_TERM"}, {"start": 151, "end": 155, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 22 includes COX-deficient muscle fibers and abnormal thalamic signal intensity. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 111, "label": "HPO_TERM"}, {"start": 137, "end": 141, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 23, who has a history of seizure-like activity. Examination also revealed a parkinsonian syndrome. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 24, who has a history of bilateral ptosis. Examination also revealed cytochrome c oxidase-negative muscle fibers. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 71, "label": "HPO_TERM"}, {"start": 99, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "Patient 25 was evaluated for an increased lactate level. The patient also presented with an adult onset and slowness of movement and a resting tremor. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 101, "label": "HPO_TERM"}, {"start": 106, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 26, a patient with a pediatric-onset disorder. Further investigation showed slurred, consistent with dysarthria and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 142, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 27 were a buildup of lactate in his bloodstream and a clinical syndrome resembling Parkinson's disease. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 133, "label": "HPO_TERM"}, {"start": 159, "end": 163, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 28, who has a history of an increased lactate level. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 78, "label": "HPO_TERM"}, {"start": 106, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient 29 was evaluated for an adult onset. The patient also presented with features of parkinsonism and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 144, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 30, a patient with a pediatric-onset disorder. Further investigation showed a deficiency in cytochrome c oxidase and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 171, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 31, a patient with drooping of both upper eyelids. Further investigation showed unclear or mumbled speech and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 32 were a seizure and a parkinsonian syndrome. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 52, "label": "HPO_TERM"}, {"start": 57, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 33, who has a history of slowness of movement and a resting tremor. Examination also revealed unclear or mumbled speech. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 34 includes epilepsy and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 53, "label": "HPO_TERM"}, {"start": 58, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "Patient 35 was evaluated for a pediatric-onset disorder. The patient also presented with slurred, consistent with dysarthria and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 36, a patient with a clinical syndrome resembling Parkinson's disease. Further investigation showed a parkinsonian syndrome and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 93, "label": "HPO_TERM"}, {"start": 124, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 190, "label": "HPO_TERM"}, {"start": 214, "end": 218, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 37 were a condition that affects the muscles used for speech and epilepsy. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 38 includes a pediatric-onset disorder and motor speech difficulties. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 99, "label": "HPO_TERM"}, {"start": 125, "end": 129, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 39 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 40 includes an increased lactate level and slurred, consistent with dysarthria. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 41, a patient with a late-onset variant of the condition. Further investigation showed an increased lactate level and hyperlactatemia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 84, "label": "HPO_TERM"}, {"start": 115, "end": 138, "label": "HPO_TERM"}, {"start": 143, "end": 157, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "Patient 42 was evaluated for an increased lactate level. The patient also presented with a buildup of lactate in his bloodstream and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 52, "label": "HPO_TERM"}, {"start": 86, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 145, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 43, a patient with a seizure. Further investigation showed a buildup of lactate in his bloodstream and a parkinsonian syndrome. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 56, "label": "HPO_TERM"}, {"start": 87, "end": 126, "label": "HPO_TERM"}, {"start": 131, "end": 153, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "Patient 44 was evaluated for drooping of both upper eyelids. The patient also presented with an increased lactate level and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 59, "label": "HPO_TERM"}, {"start": 93, "end": 116, "label": "HPO_TERM"}, {"start": 121, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 45 were a clinical syndrome resembling Parkinson's disease and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 89, "label": "HPO_TERM"}, {"start": 94, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient 46 was evaluated for bilateral ptosis. The patient also presented with an increased lactate level and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 121, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "Patient 47 was evaluated for a seizure. The patient also presented with an atypical thalamic signal and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 38, "label": "HPO_TERM"}, {"start": 72, "end": 97, "label": "HPO_TERM"}, {"start": 102, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "Patient 48 was evaluated for slurred, consistent with dysarthria. The patient also presented with hyperlactatemia and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 49 were bilateral ptosis and a seizure. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 73, "label": "HPO_TERM"}, {"start": 99, "end": 103, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 50 were an atypical thalamic signal and drooping of both upper eyelids. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 51, a patient with a pediatric-onset disorder. Further investigation showed drooping of both upper eyelids and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 52 includes a clinical syndrome resembling Parkinson's disease and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 53 were bilateral ptosis and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 81, "label": "HPO_TERM"}, {"start": 107, "end": 111, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 54, a patient with a late-onset variant of the condition. Further investigation showed signs of parkinsonism and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 84, "label": "HPO_TERM"}, {"start": 115, "end": 135, "label": "HPO_TERM"}, {"start": 140, "end": 165, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 55, who has a history of an elevated hepatic transaminase concentration. Examination also revealed signs of parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 145, "label": "HPO_TERM"}, {"start": 200, "end": 204, "label": "GENE_VARIANT"}]}
{"text": "Patient 56 was evaluated for an atypical thalamic signal. The patient also presented with slurred, consistent with dysarthria and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 57 includes hyperlactatemia and a late-onset variant of the condition. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 58 includes an increased lactate level and a buildup of lactate in his bloodstream. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 68, "label": "HPO_TERM"}, {"start": 73, "end": 112, "label": "HPO_TERM"}, {"start": 138, "end": 142, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 59, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed slowness of movement and a resting tremor. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 101, "label": "HPO_TERM"}, {"start": 129, "end": 168, "label": "HPO_TERM"}, {"start": 223, "end": 227, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 60 includes a pediatric-onset disorder and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 71, "label": "HPO_TERM"}, {"start": 76, "end": 101, "label": "HPO_TERM"}, {"start": 127, "end": 131, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 61 were an adult onset and an increased lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "Patient 62 was evaluated for a seizure disorder. The patient also presented with an increased lactate level and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 107, "label": "HPO_TERM"}, {"start": 112, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 63 were bilateral ptosis and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 84, "label": "HPO_TERM"}, {"start": 110, "end": 114, "label": "GENE_VARIANT"}]}
{"text": "Patient 64 was evaluated for parkinsonism. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 41, "label": "HPO_TERM"}, {"start": 75, "end": 100, "label": "HPO_TERM"}, {"start": 105, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 65, a patient with disease manifestation was in the pre-adolescent period. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 96, "label": "HPO_TERM"}, {"start": 127, "end": 156, "label": "HPO_TERM"}, {"start": 161, "end": 186, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 66 were a condition that affects the muscles used for speech and bradykinesia and rigidity. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 94, "label": "HPO_TERM"}, {"start": 99, "end": 123, "label": "HPO_TERM"}, {"start": 149, "end": 153, "label": "GENE_VARIANT"}]}
{"text": "Patient 67 was evaluated for an atypical thalamic signal. The patient also presented with a buildup of lactate in his bloodstream and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 141, "label": "HPO_TERM"}, {"start": 172, "end": 176, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 68, who has a history of an atypical thalamic signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 80, "label": "HPO_TERM"}, {"start": 108, "end": 146, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "Patient 69 was evaluated for an atypical thalamic signal. The patient also presented with a pediatric-onset disorder and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 70 were a parkinsonian syndrome and a clinical syndrome resembling Parkinson's disease. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 116, "label": "HPO_TERM"}, {"start": 142, "end": 146, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 71 includes a buildup of lactate in his bloodstream and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "Patient 72 was evaluated for an adult onset. The patient also presented with hyperlactatemia and a condition that affects the muscles used for speech. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 92, "label": "HPO_TERM"}, {"start": 97, "end": 148, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 73 includes a seizure and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 54, "label": "HPO_TERM"}, {"start": 59, "end": 74, "label": "HPO_TERM"}, {"start": 100, "end": 104, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 74, a patient with an increased lactate level. Further investigation showed hyperlactatemia and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 70, "label": "HPO_TERM"}, {"start": 101, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 145, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 75, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 140, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 76, who has a history of hyperlactatemia. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 69, "label": "HPO_TERM"}, {"start": 97, "end": 112, "label": "HPO_TERM"}, {"start": 167, "end": 171, "label": "GENE_VARIANT"}]}
{"text": "Patient 77 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and a buildup of lactate in his bloodstream. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "Patient 78 was evaluated for slurred, consistent with dysarthria. The patient also presented with a diagnosis of a seizure disorder and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 62, "label": "HPO_TERM"}, {"start": 96, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 157, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 79, a patient with an atypical thalamic signal. Further investigation showed bilateral ptosis and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 72, "label": "HPO_TERM"}, {"start": 103, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 144, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 80 includes signs of parkinsonism and a seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 65, "label": "HPO_TERM"}, {"start": 70, "end": 79, "label": "HPO_TERM"}, {"start": 105, "end": 109, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 81 were an abnormal thalamic MRI signal and an atypical thalamic signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 82 includes a clinical syndrome resembling Parkinson's disease and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 91, "label": "HPO_TERM"}, {"start": 96, "end": 121, "label": "HPO_TERM"}, {"start": 147, "end": 151, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 83, who has a history of an abnormal thalamic MRI signal. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 84, "label": "HPO_TERM"}, {"start": 112, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 84, who has a history of an elevated hepatic transaminase concentration. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 164, "label": "HPO_TERM"}, {"start": 219, "end": 223, "label": "GENE_VARIANT"}]}
{"text": "Patient 85 was evaluated for a condition that affects the muscles used for speech. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 80, "label": "HPO_TERM"}, {"start": 114, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 164, "label": "HPO_TERM"}, {"start": 195, "end": 199, "label": "GENE_VARIANT"}]}
{"text": "Patient 86 was evaluated for an adult onset. The patient also presented with a buildup of lactate in his bloodstream and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 117, "label": "HPO_TERM"}, {"start": 122, "end": 142, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient 87 was evaluated for bradykinesia and rigidity. The patient also presented with a pediatric-onset disorder and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 113, "label": "HPO_TERM"}, {"start": 118, "end": 132, "label": "HPO_TERM"}, {"start": 163, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 88 were hyperlactatemia and a seizure disorder. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 57, "label": "HPO_TERM"}, {"start": 62, "end": 83, "label": "HPO_TERM"}, {"start": 109, "end": 113, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 89, who has a history of a seizure disorder. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 118, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 90, a patient with a pediatric-onset disorder. Further investigation showed unclear or mumbled speech and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 149, "label": "HPO_TERM"}, {"start": 173, "end": 177, "label": "GENE_VARIANT"}]}
{"text": "Patient 91 was evaluated for an atypical thalamic signal. The patient also presented with an elevated hepatic transaminase concentration and bilateral ptosis. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 54, "label": "HPO_TERM"}, {"start": 88, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 151, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "Patient 92 was evaluated for an adult onset. The patient also presented with a seizure disorder and slurred, consistent with dysarthria. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 10, "label": "PATIENT"}, {"start": 29, "end": 44, "label": "HPO_TERM"}, {"start": 78, "end": 99, "label": "HPO_TERM"}, {"start": 104, "end": 137, "label": "HPO_TERM"}, {"start": 168, "end": 172, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 93 were a seizure disorder and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 94 includes a seizure disorder and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 35, "label": "PATIENT"}, {"start": 45, "end": 66, "label": "HPO_TERM"}, {"start": 71, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 95 were a buildup of lactate in his bloodstream and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 37, "label": "PATIENT"}, {"start": 43, "end": 82, "label": "HPO_TERM"}, {"start": 87, "end": 102, "label": "HPO_TERM"}, {"start": 128, "end": 132, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 96, a patient with a condition that affects the muscles used for speech. Further investigation showed an atypical thalamic signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 98, "label": "HPO_TERM"}, {"start": 129, "end": 154, "label": "HPO_TERM"}, {"start": 159, "end": 201, "label": "HPO_TERM"}, {"start": 225, "end": 229, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 97, who has a history of an elevated hepatic transaminase concentration. Examination also revealed poor articulation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 97, "label": "HPO_TERM"}, {"start": 125, "end": 142, "label": "HPO_TERM"}, {"start": 197, "end": 201, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 98, who has a history of a seizure. Examination also revealed poor articulation. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 32, "label": "PATIENT"}, {"start": 55, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 109, "label": "HPO_TERM"}, {"start": 164, "end": 168, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 99, a patient with an adult onset. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 30, "label": "PATIENT"}, {"start": 47, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 152, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "Patient 100 was evaluated for a seizure. The patient also presented with an increased lactate level and a late-onset variant of the condition. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 96, "label": "HPO_TERM"}, {"start": 101, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 101, who has a history of an elevated level of lactate in the blood. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 102, a patient with bilateral ptosis. Further investigation showed signs of parkinsonism and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 103, who has a history of an atypical thalamic signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 104 includes an increased lactate level and a pediatric-onset disorder. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 100, "label": "HPO_TERM"}, {"start": 126, "end": 130, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 105, who has a history of epilepsy. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 64, "label": "HPO_TERM"}, {"start": 92, "end": 134, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 106, a patient with hyperlactatemia. Further investigation showed an elevated level of lactate in the blood and a clinical syndrome resembling Parkinson's disease. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 182, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "Patient 107 was evaluated for a buildup of lactate in his bloodstream. The patient also presented with an elevated hepatic transaminase concentration and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 69, "label": "HPO_TERM"}, {"start": 103, "end": 145, "label": "HPO_TERM"}, {"start": 150, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient 108 was evaluated for an adult onset. The patient also presented with a clinical syndrome resembling Parkinson's disease and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 109 includes an adult onset and an increased lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "Patient 110 was evaluated for unclear or mumbled speech. The patient also presented with hyperlactatemia and a condition that affects the muscles used for speech. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 103, "label": "HPO_TERM"}, {"start": 108, "end": 159, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "Patient 111 was evaluated for an atypical thalamic signal. The patient also presented with an adult onset and an abnormal thalamic MRI signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 112 includes an abnormal thalamic MRI signal and poor articulation. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 97, "label": "HPO_TERM"}, {"start": 123, "end": 127, "label": "GENE_VARIANT"}]}
{"text": "Patient 113 was evaluated for an adult onset. The patient also presented with an abnormal thalamic MRI signal and poor articulation. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 108, "label": "HPO_TERM"}, {"start": 113, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 114, a patient with an adult onset. Further investigation showed a buildup of lactate in his bloodstream and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 63, "label": "HPO_TERM"}, {"start": 94, "end": 133, "label": "HPO_TERM"}, {"start": 138, "end": 167, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 115, who has a history of an atypical thalamic signal. Examination also revealed parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 121, "label": "HPO_TERM"}, {"start": 176, "end": 180, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 116, who has a history of drooping of both upper eyelids. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 86, "label": "HPO_TERM"}, {"start": 114, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 117 were a buildup of lactate in his bloodstream and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 118 were an adult onset and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 59, "label": "HPO_TERM"}, {"start": 64, "end": 93, "label": "HPO_TERM"}, {"start": 119, "end": 123, "label": "GENE_VARIANT"}]}
{"text": "Patient 119 was evaluated for an atypical thalamic signal. The patient also presented with an abnormal thalamic MRI signal and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 138, "label": "HPO_TERM"}, {"start": 169, "end": 173, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 120 includes a buildup of lactate in his bloodstream and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 105, "label": "HPO_TERM"}, {"start": 131, "end": 135, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 121, a patient with a pediatric-onset disorder. Further investigation showed a buildup of lactate in his bloodstream and hyperlactatemia. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 144, "label": "HPO_TERM"}, {"start": 149, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 122 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "Patient 123 was evaluated for an adult onset. The patient also presented with an atypical thalamic signal and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 104, "label": "HPO_TERM"}, {"start": 109, "end": 147, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 124, who has a history of poor articulation. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 73, "label": "HPO_TERM"}, {"start": 101, "end": 143, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 125, a patient with an atypical thalamic signal. Further investigation showed an adult onset and drooping of both upper eyelids. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 126, a patient with unclear or mumbled speech. Further investigation showed an elevated hepatic transaminase concentration and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 73, "label": "HPO_TERM"}, {"start": 104, "end": 146, "label": "HPO_TERM"}, {"start": 151, "end": 166, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 127, who has a history of an elevated level of lactate in the blood. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 147, "label": "HPO_TERM"}, {"start": 202, "end": 206, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 128, who has a history of signs of parkinsonism. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 76, "label": "HPO_TERM"}, {"start": 104, "end": 119, "label": "HPO_TERM"}, {"start": 174, "end": 178, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 129 includes a seizure and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 55, "label": "HPO_TERM"}, {"start": 60, "end": 80, "label": "HPO_TERM"}, {"start": 106, "end": 110, "label": "GENE_VARIANT"}]}
{"text": "Patient 130 was evaluated for drooping of both upper eyelids. The patient also presented with an atypical thalamic signal and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 60, "label": "HPO_TERM"}, {"start": 94, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 139, "label": "HPO_TERM"}, {"start": 170, "end": 174, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 131, who has a history of an elevated level of lactate in the blood. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 94, "label": "HPO_TERM"}, {"start": 122, "end": 148, "label": "HPO_TERM"}, {"start": 203, "end": 207, "label": "GENE_VARIANT"}]}
{"text": "Patient 132 was evaluated for signs of parkinsonism. The patient also presented with hyperlactatemia and a seizure. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 50, "label": "HPO_TERM"}, {"start": 84, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 112, "label": "HPO_TERM"}, {"start": 143, "end": 147, "label": "GENE_VARIANT"}]}
{"text": "Patient 133 was evaluated for an atypical thalamic signal. The patient also presented with bilateral ptosis and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 105, "label": "HPO_TERM"}, {"start": 110, "end": 130, "label": "HPO_TERM"}, {"start": 161, "end": 165, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 134, who has a history of an atypical thalamic signal. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 135, a patient with a seizure disorder. Further investigation showed an increased lactate level and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 136 were a pediatric-onset disorder and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 70, "label": "HPO_TERM"}, {"start": 75, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 137, who has a history of an atypical thalamic signal. Examination also revealed drooping of both upper eyelids. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 81, "label": "HPO_TERM"}, {"start": 109, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 138 were an atypical thalamic signal and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 139, a patient with poor articulation. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 65, "label": "HPO_TERM"}, {"start": 96, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 124, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 140, a patient with hyperlactatemia. Further investigation showed a clinical syndrome resembling Parkinson's disease and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 159, "label": "HPO_TERM"}, {"start": 183, "end": 187, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 141, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an abnormal thalamic MRI signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 142 were an elevated hepatic transaminase concentration and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 106, "label": "HPO_TERM"}, {"start": 132, "end": 136, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 143 includes an elevated level of lactate in the blood and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 104, "label": "HPO_TERM"}, {"start": 130, "end": 134, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 144, a patient with an abnormal thalamic MRI signal. Further investigation showed an adult onset and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 161, "label": "HPO_TERM"}, {"start": 185, "end": 189, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 145 includes hyperlactatemia and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 60, "label": "HPO_TERM"}, {"start": 65, "end": 90, "label": "HPO_TERM"}, {"start": 116, "end": 120, "label": "GENE_VARIANT"}]}
{"text": "Patient 146 was evaluated for poor articulation. The patient also presented with an elevated hepatic transaminase concentration and a seizure disorder. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 123, "label": "HPO_TERM"}, {"start": 128, "end": 149, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 147 includes a buildup of lactate in his bloodstream and an atypical thalamic signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 85, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 148, who has a history of an increased lactate level. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 149 were unclear or mumbled speech and an abnormal thalamic MRI signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 150, a patient with a late-onset variant of the condition. Further investigation showed an atypical thalamic signal and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 166, "label": "HPO_TERM"}, {"start": 190, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 151 includes a seizure and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 55, "label": "HPO_TERM"}, {"start": 60, "end": 75, "label": "HPO_TERM"}, {"start": 101, "end": 105, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 152, who has a history of hyperlactatemia. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 70, "label": "HPO_TERM"}, {"start": 98, "end": 124, "label": "HPO_TERM"}, {"start": 179, "end": 183, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 153, who has a history of a seizure disorder. Examination also revealed slurred, consistent with dysarthria. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 77, "label": "HPO_TERM"}, {"start": 105, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 154, a patient with a pediatric-onset disorder. Further investigation showed hyperlactatemia and a buildup of lactate in his bloodstream. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 119, "label": "HPO_TERM"}, {"start": 124, "end": 163, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 155, a patient with an elevated hepatic transaminase concentration. Further investigation showed a pediatric-onset disorder and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 90, "label": "HPO_TERM"}, {"start": 121, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 156, a patient with an increased lactate level. Further investigation showed an atypical thalamic signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 71, "label": "HPO_TERM"}, {"start": 102, "end": 127, "label": "HPO_TERM"}, {"start": 132, "end": 174, "label": "HPO_TERM"}, {"start": 198, "end": 202, "label": "GENE_VARIANT"}]}
{"text": "Patient 157 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 158, a patient with a seizure. Further investigation showed hyperlactatemia and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 57, "label": "HPO_TERM"}, {"start": 88, "end": 102, "label": "HPO_TERM"}, {"start": 107, "end": 122, "label": "HPO_TERM"}, {"start": 146, "end": 150, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 159 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 160 were an atypical thalamic signal and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 113, "label": "HPO_TERM"}, {"start": 139, "end": 143, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 161, who has a history of an elevated hepatic transaminase concentration. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 151, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 162 includes an adult onset and an abnormal thalamic MRI signal. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 163, a patient with a seizure. Further investigation showed an elevated hepatic transaminase concentration and an abnormal thalamic MRI signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 57, "label": "HPO_TERM"}, {"start": 88, "end": 130, "label": "HPO_TERM"}, {"start": 135, "end": 164, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 164, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed an atypical thalamic signal. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 102, "label": "HPO_TERM"}, {"start": 130, "end": 155, "label": "HPO_TERM"}, {"start": 210, "end": 214, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 165, who has a history of a buildup of lactate in his bloodstream. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 149, "label": "HPO_TERM"}, {"start": 204, "end": 208, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 166 were a condition that affects the muscles used for speech and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 115, "label": "HPO_TERM"}, {"start": 141, "end": 145, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 167, a patient with an abnormal thalamic MRI signal. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 77, "label": "HPO_TERM"}, {"start": 108, "end": 122, "label": "HPO_TERM"}, {"start": 127, "end": 136, "label": "HPO_TERM"}, {"start": 160, "end": 164, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 168 includes an elevated level of lactate in the blood and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 109, "label": "HPO_TERM"}, {"start": 135, "end": 139, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 169, a patient with a buildup of lactate in his bloodstream. Further investigation showed an abnormal thalamic MRI signal and an atypical thalamic signal. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 147, "label": "HPO_TERM"}, {"start": 152, "end": 177, "label": "HPO_TERM"}, {"start": 201, "end": 205, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 170 includes a seizure disorder and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 171 includes a seizure disorder and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 67, "label": "HPO_TERM"}, {"start": 72, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 172, who has a history of an abnormal thalamic MRI signal. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient 173 was evaluated for an increased lactate level. The patient also presented with an elevated level of lactate in the blood and drooping of both upper eyelids. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 160, "label": "HPO_TERM"}, {"start": 191, "end": 195, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 174 were signs of parkinsonism and a buildup of lactate in his bloodstream. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 64, "label": "HPO_TERM"}, {"start": 69, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "Patient 175 was evaluated for an atypical thalamic signal. The patient also presented with poor articulation and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 106, "label": "HPO_TERM"}, {"start": 111, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 176 includes an elevated level of lactate in the blood and hyperlactatemia. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "Patient 177 was evaluated for a seizure. The patient also presented with an atypical thalamic signal and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 39, "label": "HPO_TERM"}, {"start": 73, "end": 98, "label": "HPO_TERM"}, {"start": 103, "end": 123, "label": "HPO_TERM"}, {"start": 154, "end": 158, "label": "GENE_VARIANT"}]}
{"text": "Patient 178 was evaluated for slurred, consistent with dysarthria. The patient also presented with an elevated hepatic transaminase concentration and a seizure disorder. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 139, "label": "HPO_TERM"}, {"start": 144, "end": 165, "label": "HPO_TERM"}, {"start": 196, "end": 200, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 179, a patient with a buildup of lactate in his bloodstream. Further investigation showed an elevated level of lactate in the blood and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 87, "label": "HPO_TERM"}, {"start": 118, "end": 156, "label": "HPO_TERM"}, {"start": 161, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "Patient 180 was evaluated for unclear or mumbled speech. The patient also presented with a pediatric-onset disorder and an elevated level of lactate in the blood. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 55, "label": "HPO_TERM"}, {"start": 89, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 158, "label": "HPO_TERM"}, {"start": 189, "end": 193, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 181, who has a history of an abnormal thalamic MRI signal. Examination also revealed a buildup of lactate in his bloodstream. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 152, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 182, who has a history of slurred, consistent with dysarthria. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 89, "label": "HPO_TERM"}, {"start": 117, "end": 131, "label": "HPO_TERM"}, {"start": 186, "end": 190, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 183, who has a history of slurred, consistent with dysarthria. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 89, "label": "HPO_TERM"}, {"start": 117, "end": 132, "label": "HPO_TERM"}, {"start": 187, "end": 191, "label": "GENE_VARIANT"}]}
{"text": "Patient 184 was evaluated for an adult onset. The patient also presented with an elevated hepatic transaminase concentration and hyperlactatemia. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 45, "label": "HPO_TERM"}, {"start": 79, "end": 121, "label": "HPO_TERM"}, {"start": 126, "end": 140, "label": "HPO_TERM"}, {"start": 171, "end": 175, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 185, who has a history of an increased lactate level. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 79, "label": "HPO_TERM"}, {"start": 107, "end": 122, "label": "HPO_TERM"}, {"start": 177, "end": 181, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 186, who has a history of a clinical syndrome resembling Parkinson's disease. Examination also revealed a seizure. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 102, "label": "HPO_TERM"}, {"start": 130, "end": 139, "label": "HPO_TERM"}, {"start": 194, "end": 198, "label": "GENE_VARIANT"}]}
{"text": "Patient 187 was evaluated for slurred, consistent with dysarthria. The patient also presented with hyperlactatemia and an adult onset. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 63, "label": "HPO_TERM"}, {"start": 97, "end": 111, "label": "HPO_TERM"}, {"start": 116, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 188 includes an elevated level of lactate in the blood and slurred, consistent with dysarthria. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 84, "label": "HPO_TERM"}, {"start": 89, "end": 122, "label": "HPO_TERM"}, {"start": 148, "end": 152, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 189 were an abnormal thalamic MRI signal and poor articulation. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 73, "label": "HPO_TERM"}, {"start": 78, "end": 95, "label": "HPO_TERM"}, {"start": 121, "end": 125, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 190 includes an elevated hepatic transaminase concentration and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 88, "label": "HPO_TERM"}, {"start": 93, "end": 108, "label": "HPO_TERM"}, {"start": 134, "end": 138, "label": "GENE_VARIANT"}]}
{"text": "Patient 191 was evaluated for a pediatric-onset disorder. The patient also presented with signs of parkinsonism and bilateral ptosis. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 110, "label": "HPO_TERM"}, {"start": 115, "end": 131, "label": "HPO_TERM"}, {"start": 162, "end": 166, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 192 were an atypical thalamic signal and signs of parkinsonism. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 69, "label": "HPO_TERM"}, {"start": 74, "end": 94, "label": "HPO_TERM"}, {"start": 120, "end": 124, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 193, who has a history of an abnormal thalamic MRI signal. Examination also revealed signs of parkinsonism. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 133, "label": "HPO_TERM"}, {"start": 188, "end": 192, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 194 includes drooping of both upper eyelids and an adult onset. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 76, "label": "HPO_TERM"}, {"start": 81, "end": 96, "label": "HPO_TERM"}, {"start": 122, "end": 126, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 195, who has a history of a seizure. Examination also revealed an elevated hepatic transaminase concentration. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 65, "label": "HPO_TERM"}, {"start": 93, "end": 135, "label": "HPO_TERM"}, {"start": 190, "end": 194, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 196 includes an adult onset and signs of parkinsonism. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 86, "label": "HPO_TERM"}, {"start": 112, "end": 116, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 197, a patient with a pediatric-onset disorder. Further investigation showed an abnormal thalamic MRI signal and an adult onset. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 154, "label": "HPO_TERM"}, {"start": 178, "end": 182, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 198 were an elevated hepatic transaminase concentration and an increased lactate level. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 86, "label": "HPO_TERM"}, {"start": 91, "end": 114, "label": "HPO_TERM"}, {"start": 140, "end": 144, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 199 were hyperlactatemia and an atypical thalamic signal. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 58, "label": "HPO_TERM"}, {"start": 63, "end": 88, "label": "HPO_TERM"}, {"start": 114, "end": 118, "label": "GENE_VARIANT"}]}
{"text": "The primary symptoms for Patient 200 were a buildup of lactate in his bloodstream and an adult onset. Analysis of the POLG gene was performed.", "spans": [{"start": 27, "end": 38, "label": "PATIENT"}, {"start": 44, "end": 83, "label": "HPO_TERM"}, {"start": 88, "end": 103, "label": "HPO_TERM"}, {"start": 129, "end": 133, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 201, who has a history of an abnormal thalamic MRI signal. Examination also revealed an elevated level of lactate in the blood. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 151, "label": "HPO_TERM"}, {"start": 206, "end": 210, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 202, a patient with a pediatric-onset disorder. Further investigation showed an abnormal thalamic MRI signal and an elevated hepatic transaminase concentration. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 74, "label": "HPO_TERM"}, {"start": 105, "end": 134, "label": "HPO_TERM"}, {"start": 139, "end": 181, "label": "HPO_TERM"}, {"start": 205, "end": 209, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 203, who has a history of a seizure. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 65, "label": "HPO_TERM"}, {"start": 93, "end": 108, "label": "HPO_TERM"}, {"start": 163, "end": 167, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 204, who has a history of a buildup of lactate in his bloodstream. Examination also revealed an adult onset. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 95, "label": "HPO_TERM"}, {"start": 123, "end": 138, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient 205 was evaluated for poor articulation. The patient also presented with hyperlactatemia and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 47, "label": "HPO_TERM"}, {"start": 81, "end": 95, "label": "HPO_TERM"}, {"start": 100, "end": 125, "label": "HPO_TERM"}, {"start": 156, "end": 160, "label": "GENE_VARIANT"}]}
{"text": "Patient 206 was evaluated for a pediatric-onset disorder. The patient also presented with an elevated hepatic transaminase concentration and an atypical thalamic signal. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 132, "label": "HPO_TERM"}, {"start": 137, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "Patient 207 was evaluated for a pediatric-onset disorder. The patient also presented with an atypical thalamic signal and an elevated hepatic transaminase concentration. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 56, "label": "HPO_TERM"}, {"start": 90, "end": 115, "label": "HPO_TERM"}, {"start": 120, "end": 162, "label": "HPO_TERM"}, {"start": 193, "end": 197, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 208, a patient with hyperlactatemia. Further investigation showed an elevated level of lactate in the blood and signs of parkinsonism. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 62, "label": "HPO_TERM"}, {"start": 93, "end": 131, "label": "HPO_TERM"}, {"start": 136, "end": 156, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "Patient 209 was evaluated for an increased lactate level. The patient also presented with an elevated level of lactate in the blood and signs of parkinsonism. Subsequent sequencing of the POLG gene revealed a pathogenic variant.", "spans": [{"start": 0, "end": 11, "label": "PATIENT"}, {"start": 30, "end": 53, "label": "HPO_TERM"}, {"start": 87, "end": 125, "label": "HPO_TERM"}, {"start": 130, "end": 150, "label": "HPO_TERM"}, {"start": 181, "end": 185, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 210, a patient with bilateral ptosis. Further investigation showed an increased lactate level and slurred, consistent with dysarthria. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 64, "label": "HPO_TERM"}, {"start": 95, "end": 118, "label": "HPO_TERM"}, {"start": 123, "end": 156, "label": "HPO_TERM"}, {"start": 180, "end": 184, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 211 includes an adult onset and an increased lactate level. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 61, "label": "HPO_TERM"}, {"start": 66, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 212, a patient with a seizure disorder. Further investigation showed an abnormal thalamic MRI signal and poor articulation. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 129, "label": "HPO_TERM"}, {"start": 134, "end": 151, "label": "HPO_TERM"}, {"start": 175, "end": 179, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 213, a patient with a seizure disorder. Further investigation showed hyperlactatemia and a seizure. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 69, "label": "HPO_TERM"}, {"start": 100, "end": 114, "label": "HPO_TERM"}, {"start": 119, "end": 128, "label": "HPO_TERM"}, {"start": 152, "end": 156, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 214, who has a history of an abnormal thalamic MRI signal. Examination also revealed hyperlactatemia. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 85, "label": "HPO_TERM"}, {"start": 113, "end": 127, "label": "HPO_TERM"}, {"start": 182, "end": 186, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 215 includes an abnormal thalamic MRI signal and a seizure. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 75, "label": "HPO_TERM"}, {"start": 80, "end": 89, "label": "HPO_TERM"}, {"start": 115, "end": 119, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 216, who has a history of an elevated hepatic transaminase concentration. Examination also revealed a pediatric-onset disorder. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 98, "label": "HPO_TERM"}, {"start": 126, "end": 152, "label": "HPO_TERM"}, {"start": 207, "end": 211, "label": "GENE_VARIANT"}]}
{"text": "We report the case of Patient 217, who has a history of An elevated concentration of liver transaminases. Examination also revealed a history of recurrent seizures. The underlying cause was traced to a mutation in the POLG gene.", "spans": [{"start": 22, "end": 33, "label": "PATIENT"}, {"start": 56, "end": 104, "label": "HPO_TERM"}, {"start": 132, "end": 163, "label": "HPO_TERM"}, {"start": 218, "end": 222, "label": "GENE_VARIANT"}]}
{"text": "This report details Patient 218, a patient with a late-onset variant of the condition. Further investigation showed unclear or mumbled speech and hepatic enzyme levels were above the normal range. A known variant in the POLG gene was identified.", "spans": [{"start": 20, "end": 31, "label": "PATIENT"}, {"start": 48, "end": 85, "label": "HPO_TERM"}, {"start": 116, "end": 141, "label": "HPO_TERM"}, {"start": 146, "end": 192, "label": "HPO_TERM"}, {"start": 216, "end": 220, "label": "GENE_VARIANT"}]}
{"text": "The clinical profile for Patient 219 includes a pediatric-onset disorder and drooping of both upper eyelids. Genetic analysis of the POLG gene confirmed the diagnosis.", "spans": [{"start": 25, "end": 36, "label": "PATIENT"}, {"start": 46, "end": 72, "label": "HPO_TERM"}, {"start": 77, "end": 107, "label": "HPO_TERM"}, {"start": 133, "end": 137, "label": "GENE_VARIANT"}]}